Malaria News and Research

Latest Malaria News and Research

Natural compounds could combat drug-resistant malaria and babesiosis

As parasites become increasingly resistant to existing drugs, researchers at the University of California, Riverside are working to develop a new generation of treatments for two serious infectious diseases: malaria and babesiosis.

31 Jul 2026

NIH funds mosquito genetics research to curb deadly disease spread

Mosquito-borne pathogens, including zika, yellow fever and other illnesses have serious and worldwide impacts on human health.

29 Jul 2026

Climate change shifts malaria risk across sub-Saharan Africa

Malaria is the deadliest climate-sensitive infectious disease. Yet, researchers and public health officials have long argued over how climate change has shaped its spread.

29 Jul 2026

Taiwan Biobank data reveals ongoing natural selection in living humans

For more than a century, scientists have sought to reconstruct human evolution using diverse lines of evidence, including fossils, genetic variation across populations, and ancient DNA.

24 Jul 2026

NYU Abu Dhabi scientists discover new vulnerability in malaria parasite

Researchers at NYU Abu Dhabi have discovered that the malaria parasite relies on a specific type of fat to survive and multiply within the human host, uncovering a previously unknown vulnerability that could help guide future treatments.

24 Jul 2026

New battery-powered device detects Bundibugyo Ebola virus in thirty minutes

Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV).

17 Jul 2026

Irritable patients changed physicians’ emotions but not decisions

Irritable patient behavior influences physician emotions but does not alter clinical assessments, emphasizing the need for emotional resilience training.

15 Jul 2026

Tracking Lassa fever survivors provides crucial clues for future vaccines

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the launch of a research study to understand how Lassa fever survivors fight and overcome Lassa virus infection.

14 Jul 2026

Researchers develop low-cost catnip mosquito repellent for rural Uganda

Plant researchers from Wales and Uganda have collaborated on a community enterprise project in rural Uganda, becoming the first to create affordable and highly effective mosquito repellent distilled from locally grown catnip plants.

7 Jul 2026

New structural insights overturn old assumptions about malaria entry

For nearly half a century, scientists have known that malaria parasites force their way into human red blood cells through a ring-shaped structure called the moving junction.

30 Jun 2026

New schistosomiasis vaccine induces robust immune memory responses

For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must train the body to remember the response so it can fight that same disease in the future.

29 Jun 2026

Amazon land use patterns reveal where vector-borne diseases collide

Researchers found that malaria-Chagas and dengue-ATL hotspots in the Brazilian Amazon aligned with distinct agrarian, socioeconomic, and environmental landscapes. The findings suggest that disease surveillance should account for land use, poverty, forest structure, mining, and local livelihoods rather than treating each infection in isolation.

22 Jun 2026

Sidewalk yeast species could lead to eco-friendly mosquito traps

An orange-colored yeast species isolated from a Baltimore sidewalk several years ago could be the basis of eco-friendly mosquito traps that reduce malaria transmission, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.

17 Jun 2026

Global analysis exposes wide regional disparities in insecticide-treated net performance

A major analysis of 25 studies across Africa and Asia finds that insecticide-treated nets cut malaria cases by up to 68% - but highlights challenges that threaten to undermine their long-term impact.

15 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Global decline in child mortality slowed down significantly since 2015

Global progress in reducing preventable deaths among newborn babies, children, and adolescents has slowed substantially since 2015, and many countries risk missing international child survival targets by 2030, find a series of papers published by The BMJ today.

4 Jun 2026

Cross-reactive T cells target measles and dangerous Nipah viruses

T cells are some of the immune system's most important warriors. They can stop tumor growth and even fight off severe infections.

2 Jun 2026

Stem cell transplantation is the most cost-effective sickle cell treatment

Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new research published in Blood.

2 Jun 2026

Hydroxychloroquine lowers heart risks in skin lupus patients

A study led by investigators from Johns Hopkins Medicine found that some patients with discoid lupus erythematosus - a form of skin lupus commonly diagnosed in young to middle-aged Black women that causes disc-shaped plaques to form on the body - were less likely to experience complications, such as diabetes, hypertension and coronary artery disease if they were prescribed hydroxychloroquine.

26 May 2026

PAHO and The Carter Center join hands on the elimination of onchocerciasis across the Americas

The Pan American Health Organization (PAHO) and The Carter Center signed a Technical Cooperation Agreement today to strengthen collaboration on the elimination of onchocerciasis — also known as river blindness — and other communicable diseases in the Americas.

21 May 2026